Michael F. Good

16.9k total citations
347 papers, 13.2k citations indexed

About

Michael F. Good is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Molecular Biology. According to data from OpenAlex, Michael F. Good has authored 347 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 278 papers in Public Health, Environmental and Occupational Health, 123 papers in Immunology and 101 papers in Molecular Biology. Recurrent topics in Michael F. Good's work include Malaria Research and Control (158 papers), Streptococcal Infections and Treatments (113 papers) and Mosquito-borne diseases and control (92 papers). Michael F. Good is often cited by papers focused on Malaria Research and Control (158 papers), Streptococcal Infections and Treatments (113 papers) and Mosquito-borne diseases and control (92 papers). Michael F. Good collaborates with scholars based in Australia, United States and United Kingdom. Michael F. Good's co-authors include Louis H. Miller, Michael R. Batzloff, István Tóth, Jay A. Berzofsky, Denise L. Doolan, Michelle Wykes, Danielle I. Stanisic, Christian Engwerda, Chakrit Hirunpetcharat and Isabella A. Quakyi and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael F. Good

339 papers receiving 12.9k citations

Peers

Countries citing papers authored by Michael F. Good

Since Specialization

Citations

This map shows the geographic impact of Michael F. Good's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael F. Good with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael F. Good more than expected).

Fields of papers citing papers by Michael F. Good

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael F. Good. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael F. Good. The network helps show where Michael F. Good may publish in the future.

Co-authorship network of co-authors of Michael F. Good

This figure shows the co-authorship network connecting the top 25 collaborators of Michael F. Good. A scholar is included among the top collaborators of Michael F. Good based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael F. Good. Michael F. Good is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Low-dose interleukin 2 therapy halts the progression of post-streptococcal autoimmune complications in a rat model of rheumatic heart disease 2025 ·mBio ·(unknown), Natkunam Ketheesan, Michael F. Good, Manisha Pandey, Ailin Lepletier	0
2	Disruption of IL-17-mediated immunosurveillance in the respiratory mucosa results in invasive Streptococcus pyogenes infection 2024 ·Frontiers in Immunology ·(unknown), Ailin Lepletier, Victoria Ozberk, (unknown), (unknown), (unknown), (unknown), Allan Hicks, Ali Zaid, Michael F. Good, Manisha Pandey	1
3	Chimeric hepatitis B surface antigen virus-like particles expressing the strep A epitope p17 elicit a humoral immune response in mice 2024 ·Heliyon* ·(unknown), Tarek A. Ahmad, Victoria Ozberk, Manisha Pandey, Michael F. Good, Michael Kotiw	0
4	Streptococcus pyogenes vaccine candidates do not induce autoimmune responses in a rheumatic heart disease model 2023 ·npj Vaccines ·Simone Reynolds, (unknown), Adam S. Hamlin, Ailin Lepletier, Manisha Pandey, Natkunam Ketheesan, Michael F. Good	10
5	Malaria Vaccines: Progress to Date 2023 ·BioDrugs ·Danielle I. Stanisic, Michael F. Good	30
6	A CAF01-adjuvanted whole asexual blood-stage liposomal malaria vaccine induces a CD4 ⁺ T-cell-dependent strain-transcending protective immunity in rodent models 2023 ·mBio ·(unknown), Mei‐Fong Ho, Mehfuz Zaman, Emily Cooper, (unknown), (unknown), (unknown), Reshma J. Nevagi, Lynette Beattie, Declan G. Murphy, Danielle I. Stanisic, Michael F. Good	1
7	Streptolysin O Deficiency in Streptococcus pyogenes M1T1 covR/S Mutant Strain Attenuates Virulence in In Vitro and In Vivo Infection Models 2023 ·mBio ·(unknown), Simone Reynolds, Victoria Ozberk, (unknown), (unknown), Mehfuz Zaman, Mark J. Walker, Michael R. Batzloff, Mark R. Davies, Michael F. Good, Manisha Pandey	6
8	Hiding in plain sight: an epitope-based strategy for a subunit malaria vaccine 2023 ·Trends in Parasitology ·Michael F. Good, Stephanie K. Yanow	3
9	A vaccine for human babesiosis: prospects and feasibility 2022 ·Trends in Parasitology ·(unknown), (unknown), Sanjai Kumar, Michael F. Good, Danielle I. Stanisic	4
10	Polyphenylalanine as a self-adjuvanting delivery system for peptide-based vaccines: the role of peptide conformation 2022 ·Australian Journal of Chemistry ·Mariusz Skwarczyński, (unknown), Victoria Ozberk, Ashwini Kumar Giddam, Zeinab G. Khalil, Manisha Pandey, Waleed M. Hussein, Reshma J. Nevagi, Michael R. Batzloff, Robert J. Capon, Michael F. Good, István Tóth	4
11	Investigation of liposomal self-adjuvanting peptide epitopes derived from conserved blood-stage Plasmodium antigens 2022 ·PLoS ONE ·(unknown), Mei‐Fong Ho, (unknown), Ahmed O. Shalash, (unknown), Waleed M. Hussein, Danielle I. Stanisic, Michael F. Good, Mariusz Skwarczyński, István Tóth	1
12	M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP) 2020 ·npj Vaccines ·(unknown), (unknown), Simone Reynolds, (unknown), (unknown), (unknown), (unknown), Alexandra C. I. Depelsenaire, (unknown), (unknown), Angus H. Forster, Manisha Pandey, Michael F. Good	14
13	Streptococcus: An organism causing diseases beyond neglect 2020 ·PLoS neglected tropical diseases ·Michael F. Good	11
14	Challenges and strategies for developing efficacious and long-lasting malaria vaccines 2019 ·Science Translational Medicine ·James G. Beeson, Liriye Kurtovic, Carlota Dobaño, D. Herbert Opi, Jo-Anne Chan, Gaoqian Feng, Michael F. Good, Linda Reiling, Michelle J. Boyle	137
15	Whole parasite vaccines for the asexual blood stages of Plasmodium 2019 ·Immunological Reviews ·Michael F. Good, Danielle I. Stanisic	9
16	Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice 2019 ·Science Advances ·Manisha Pandey, (unknown), Victoria Ozberk, Zhenjun Chen, Matthew A. Croxen, Jessica Powell, (unknown), (unknown), Freda E.‐C. Jen, James McCluskey, Jenny Robson, Gregory J. Tyrrell, Michael F. Good	11
17	Controlled Human Malaria Infection: Applications, Advances, and Challenges 2017 ·Infection and Immunity ·Danielle I. Stanisic, James McCarthy, Michael F. Good	79
18	Enhancing Vaccine Efficacy by Engineering a Complex Synthetic Peptide To Become a Super Immunogen 2017 ·The Journal of Immunology ·Therése Nordström, Manisha Pandey, (unknown), Jessica Powell, Zachary N. Phillips, (unknown), Ashwini Kumar Giddam, Yun Shi, Thomas Haselhorst, Mark von Itzstein, Michael R. Batzloff, Michael F. Good	17
19	Lipid core peptide/poly(lactic-co-glycolic acid) as a highly potent intranasal vaccine delivery system against Group A streptococcus 2016 ·International Journal of Pharmaceutics ·Nirmal Marasini, Zeinab G. Khalil, Ashwini Kumar Giddam, Khairunnisa Abdul Ghaffar, Waleed M. Hussein, Robert J. Capon, Michael R. Batzloff, Michael F. Good, Mariusz Skwarczyński, István Tóth	35
20	Apoptosis and dysfunction of blood dendritic cells in patients with falciparum and vivax malaria 2013 ·The Journal of Experimental Medicine ·Alberto Pinzón‐Charry, Tonia Woodberry, Vivian Kienzle, Virginia McPhun, Gabriela Minigo, Daniel A. Lampah, Enny Kenangalem, Christian Engwerda, J. Alejandro López, Nicholas M. Anstey, Michael F. Good	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact